Histological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and Meta-analysis

References

• Martinelli P, Sarno L, Maruotti GM, et al. Chorioamnionitis and prematurity: A critical review. J Matern Fetal Neonatal Med. 2012;25(Suppl 4):29–31.
   PubMed Web of Science ®Google Scholar
• Tita ATN, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339–354.
   PubMed Web of Science ®Google Scholar
• Rouse DJ, Landon M, Leveno KJ, et al. The maternal-fetal medicine units cesarean registry: chorioamnionitis at term and its duration – relationship to outcomes. Am J Obstet Gynecol. 2004;191(1):211–216.
   PubMed Web of Science ®Google Scholar
• Thomas W, Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology. 2011;99(3):177–187.
   PubMed Web of Science ®Google Scholar
• Bersani I, Thomas W, Speer CP. Chorioamnionitis – the good or the evil for neonatal outcome? J Matern Fetal Neonatal Med. 2012;25(Sup 1):12–16.
   PubMed Web of Science ®Google Scholar
• Watterberg KL, Demers LM, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;97(2):210–215.
   PubMed Web of Science ®Google Scholar
• Mcdowell KM, Jobe AH, Fenchel M, et al. Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants. Annals ATS. 2016;13(6):867–876.
   Web of Science ®Google Scholar
• Higgins JPT. editor. Contents search. Cochrane handbook for systematic reviews of interventions version 5.1.0 updated March 2011. The Cochrane Collaboration, 2011.
   Google Scholar
• Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–716.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012.
   PubMed Web of Science ®Google Scholar
• Ahn HM, Park EA, Cho SJ, et al. The Association of Histological Chorioamnionitis and Antenatal Steroids on Neonatal Outcome in preterm infants born at less than thirty-four weeks’ gestation. Neonatology. 2012;102(4):259–264.
   PubMed Web of Science ®Google Scholar
• Arayici S, Kadioglu Simsek G, Oncel MY, et al. The effect of histological chorioamnionitis on the short-term outcome of preterm infants ≤32 weeks: a single-center study. J Matern Fetal Neonatal Med. 2014;27(11):1129–1133.
   PubMed Web of Science ®Google Scholar
• De FC, Toti P, Parrini S, et al. Histologic chorioamnionitis and severity of illness in very low birth weight newborns. Pediatr Crit Care Med. 2005;6(3):298–302.
   PubMedGoogle Scholar
• Dempsey E, Chen MF, Kokottis T, et al. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol. 2005;22(03):155–159.
   PubMed Web of Science ®Google Scholar
• Elimian A, Verma U, Beneck D, et al. Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet Gynecol. 2000;96(3):333–336.
   Google Scholar
• Holcroft CJ, Askin FB, Patra A, et al. Are histopathologic chorioamnionitis and funisitis associated with metabolic acidosis in the preterm fetus? Am J Obstet Gynecol. 2004;191(6):2010–2015.
   PubMed Web of Science ®Google Scholar
• Huetz N, Triau S, Leboucher B, et al. Association of severe placental inflammation with death prior to discharge and cerebral palsy in preterm infants. BJOG: Int J Obstet Gy. 2016;123(12):1956–1963.
   PubMed Web of Science ®Google Scholar
• Kosuge S, Ohkuchi A, Minakami H, et al. Influence of chorioamnionitis on survival and morbidity in singletons live-born at ∞ 32 weeks of gestation. Acta Obstet Gynecol Scand. 2000;79:861–865.
   PubMed Web of Science ®Google Scholar
• Lee SM, Park JW, Kim BJ, et al. Acute histologic chorioamnionitis is a risk factor for adverse neonatal outcome in late preterm birth after preterm premature rupture of membranes. PLoS One. 2013;8(12):e79941.
   PubMed Web of Science ®Google Scholar
• Liu Z, Tang Z, Li J, et al. Effects of placental inflammation on neonatal outcome in preterm infants. Pediatr Neonatol. 2014;55(1):35–40.
   PubMed Web of Science ®Google Scholar
• Ogunyemi D, Murillo M, Jackson U, et al. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13(2):102–109.
   PubMedGoogle Scholar
• Seliga-Siwecka JP, Kornacka MK. Neonatal outcome of preterm infants born to mothers with abnormal genital tract colonisation and chorioamnionitis: a cohort study. Early Hum Dev. 2013;89(5):271–275.
   PubMed Web of Science ®Google Scholar
• Stepan M, Cobo T, Maly J, et al. Neonatal outcomes in subgroups of women with preterm prelabor rupture of membranes before 34 weeks. J Matern Fetal Neonatal Med. 2015;29(14):2373–2377.
   PubMed Web of Science ®Google Scholar
• Tsiartas P, Kacerovsky M, Musilova I, et al. The association between histological chorioamnionitis, funisitis and neonatal outcome in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2013;26(13):1332–1336.
   PubMed Web of Science ®Google Scholar
• Choi CW, Kim BIl, Joung KE, et al. Decreased Expression of transforming growth factor-beta1 in bronchoalveolar lavage Cells of preterm Infants with Maternal chorioamnionitis. J Korean Med Sci. 2008;23(4):609–615.
   PubMed Web of Science ®Google Scholar
• Natarajan G, Glibetic M, Thomas RL, et al. Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants. Amer J Perinatol. 2008;25(08):491–497.
   PubMed Web of Science ®Google Scholar
• Ohyama M, Itani Y, Yamanaka M, et al. Re-evaluation of chorioamnionitis and funisitis with a special reference to subacute chorioamnionitis. Hum Pathol. 2002;33(2):183–190.
   PubMed Web of Science ®Google Scholar
• Richardson BS, Wakim E, daSilva O, et al. Preterm histologic chorioamnionitis: impact on cord gas and pH values and neonatal outcome. Am J Obstet Gynecol. 2006;195(5):1357–1365.
   PubMed Web of Science ®Google Scholar
• Dessardo NS, Mustać E, Dessardo S, et al. Chorioamnionitis and chronic lung disease of prematurity: a path analysis of causality. Amer J Perinatol. 2012;29(2):133–140.
   PubMed Web of Science ®Google Scholar
• Kent A, Dahlstrom JE. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia. J Paediatr Child Health. 2004;40(7):356–359.
   PubMed Web of Science ®Google Scholar
• Nasef N, Shabaan AE, Schurr P, et al. Effect of clinical and histological chorioamnionitis on the outcome of preterm infants. Am J Perinatol. 2013;30(1):59–68.
   PubMed Web of Science ®Google Scholar
• Perrone S, Toti P, Toti MS, et al. Perinatal outcome and placental histological characteristics: a single-center study. J Matern Fetal Neonatal Med. 2012;25(Sup1):110–113.
   PubMed Web of Science ®Google Scholar
• Polam S, Koons A, Anwar M, et al. Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants. Arch Pediatr Adolesc Med. 2005;159(11):1032–1035.
   PubMedGoogle Scholar
• Prendergast M, May C, Broughton S, et al. Chorioamnionitis, lung function and bronchopulmonary dysplasia in prematurely born infants. Arch Dis Child Fetal Neonatal Ed. 2011;96(4):F270–F274.
   PubMed Web of Science ®Google Scholar
• Schlapbach LJ, Ersch J, Adams M, et al. Impact of chorioamnionitis and preeclampsia on neurodevelopmental outcome in preterm infants below 32 weeks gestational age. Acta Paediatr. 2010;99(10):1504–1509.
   PubMed Web of Science ®Google Scholar
• Wirbelauer J, Thomas W, Speer CP. Response of leukocytes and nucleated red blood cells in very low-birth weight preterm infants after exposure to intrauterine inflammation. J Matern Fetal Neonatal Med. 2011;24(2):348–353.
   PubMed Web of Science ®Google Scholar
• Curley AE, Sweet DG, Thornton CM, et al. Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease. Am J Obstet Gynecol. 2003;188(4):871–875.
   PubMed Web of Science ®Google Scholar
• Honma Y, Yada Y, Takahashi N, et al. Certain type of chronic lung disease of newborns is associated with Ureaplasma urealyticum infection in utero. Pediatr Int. 2007;49(4):479–484.
   PubMed Web of Science ®Google Scholar
• Kirchner L, Helmer H, Heinze G, et al. Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):44–50.
   PubMed Web of Science ®Google Scholar
• Nishimaki S, Schima Y, Sato M, et al. Clinical and laboratory observations urinary β 2-microglobulin in premature infants with chorioamnionitis and chronic lung disease. 2003;143:120–122.
   Google Scholar
• Kunzmann S, Collins JJP, Kuypers E, et al. Thrown off balance: the effect of antenatal inflammation on the developing lung and immune system. Am J Obstet Gynecol. 2013;208(6):429–437.
   PubMed Web of Science ®Google Scholar
• Kuypers E, Collins JJP, Kramer BW, et al. Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol. 2012;302(4):L380–L389.
   PubMed Web of Science ®Google Scholar
• Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest. 1997;99(12):2992–2999.
   PubMed Web of Science ®Google Scholar
• Hartling L, Liang Y, Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2012;97(1):F8–F17.
   PubMed Web of Science ®Google Scholar
• Ameenudeen S, Boo NY, Chan LG. Risk factors associated with chronic lung disease in Malaysian very low birthweight infants. Med J Malaysia. 2007;62(1):40–45.
   PubMedGoogle Scholar
• Baud O, Zupan V, Lacaze-Masmonteil T, et al. The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants. BJOG:An international journal of O&G. 2000;107(7):877–884.
   PubMed Web of Science ®Google Scholar
• Jónsson B, Rylander M, Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. SPAE. 1998;87(10):1079–1084.
   Google Scholar
• Soraisham AS, Singhal N, Mcmillan DD, et al. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol. 2009;200(4):372.e1–372.e6.
   PubMed Web of Science ®Google Scholar
• Woynarowska M, Rutkowska M, Szamotulska K. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates]. Med Wieku Rozwoj. 2008;12(4 Pt 1):933–941.
   PubMedGoogle Scholar
• Bagchi A, Viscardi RM, Taciak V, et al. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res. 1994;36(2):244–252.
   PubMed Web of Science ®Google Scholar
• Cederqvist K, Haglund C, Heikkilä P, et al. Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants. Pediatrics. 2003;112(3):570–577.
   PubMed Web of Science ®Google Scholar
• Lamboley-Gilmert G, Lacaze-Masmonteil T. Neonatologists of the Curosurf Postmarketing French Study. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study. Pediatr Drugs. 2003;5(9):639–645.
   PubMedGoogle Scholar
• Hernández-Ronquillo L, Téllez-Zenteno JF, Weder-Cisneros N, et al. Risk factors for the development of bronchopulmonary dysplasia: a case-control study. Arch Med Res. 2004;35(6):549–553.
   PubMed Web of Science ®Google Scholar
• Kazzi SNJ, Kim UO, Quasney MW, et al. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics. 2004;114(2):e243–e248.
   PubMed Web of Science ®Google Scholar
• Lin HC, Su BH, Chang JS, et al. Nonassociation of interleukin 4 intron 3 and 590 promoter polymorphisms with bronchopulmonary dysplasia for ventilated preterm infants. Biol Neonate. 2005;87(3):181–186.
   PubMedGoogle Scholar
• Colaizy TT, Morris CD, Lapidus J, et al. Detection of ureaplasma DNA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors. Pediatr Res. 2007;61(5, Part 1):578–583.
   PubMed Web of Science ®Google Scholar
• Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res. 2004;55(6):1009–1017.
   PubMed Web of Science ®Google Scholar
• Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonat Med. 2006;11(5):296–301.
   PubMed Web of Science ®Google Scholar
• Abele-Horn M, Genzel-Boroviczény O, Uhlig T, et al. Ureaplasma urealyticum colonization and bronchopulmonary dysplasia: a comparative prospective multicentre study. Eur J Pediatr. 1998;157(12):1004–1011.
   PubMed Web of Science ®Google Scholar
• Watterberg KL, Gerdes JS, Gifford KL, et al. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics. 1999;104(6):1258–1263.
   PubMed Web of Science ®Google Scholar
• Mu SC, Lin CH, Chen YL, et al. Impact on neonatal outcome and anthropometric growth in very low birth weight infants with histological chorioamnionitis. J Formos Med Assoc. 2008;107(4):304–310.
   PubMed Web of Science ®Google Scholar
• Jobe AH. Mechanisms of lung injury and bronchopulmonary dysplasia. Amer J Perinatol. 2016;33(11):1076–1078.
   PubMed Web of Science ®Google Scholar
• De Felice C, Toti P, Parrini S, et al. Histologic chorioamnionitis and severity of illness in very low birth weight newborns. Pediatr Crit Care Med. 2005;6(3):298–302.
   Google Scholar